Alliance Pharma PLC received a notification of major holdings from Van Lanschot Kempen Investment Management NV. The reason for notification was an acquisition or disposal of voting rights, with the threshold being crossed on 12th June 2024. The total positions of Van Lanschot Kempen Investment Management NV show a 4.827550% of voting rights attached to shares, with a total of 26,088,068 voting rights held in the issuer.
The notification also includes details of the resulting situation on the date the threshold was crossed or reached, with 4.827550% of direct voting rights and no indirect voting rights. Additionally, there were no financial instruments with similar economic effect according to (DTR5.3.1R.(1) (b)).
The person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer. The completion date of the notification was 13th June 2024.
This notification provides insight into the changes in voting rights within Alliance Pharma PLC, specifically the acquisition or disposal of voting rights by Van Lanschot Kempen Investment Management NV.